Evidence map›Paper›PMID 38079398›Full record

ArticlePloS one2023

Antimicrobial activity of silver-copper coating against aerosols containing surrogate respiratory viruses and bacteria.

Lorena Reyes-Carmona, Omar A Sepúlveda-Robles, Argelia Almaguer-Flores, Juan Manuel Bello-Lopez, Carlos Ramos-Vilchis, Sandra E Rodil

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lorena Reyes-CarmonaLaboratorio de Biointerfases, DEPeI, Facultad de Odontología, Universidad Nacional Autónoma de México, CDMX, México.ORCID 0000-0001-8692-4877
Omar A Sepúlveda-RoblesUnidad de Investigación Médica en Genética Humana, UMAE Hospital de Pediatría, Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), CDMX, México.ORCID 0000-0003-2152-3954
Argelia Almaguer-FloresLaboratorio de Biointerfases, DEPeI, Facultad de Odontología, Universidad Nacional Autónoma de México, CDMX, México.ORCID 0000-0003-0014-9772
Juan Manuel Bello-LopezDirección de Investigación, Hospital Juárez de México, Magdalena de las Salinas, CDMX, México.ORCID 0000-0002-9957-3807
Carlos Ramos-VilchisInstituto de Investigaciones en Materiales, Universidad Nacional Autónoma de México, CDMX, México.
Sandra E RodilInstituto de Investigaciones en Materiales, Universidad Nacional Autónoma de México, CDMX, México.ORCID 0000-0002-0275-4418
Universidad Nacional Autónoma de México · MXHospital Juárez de México · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The transmission of bacteria and respiratory viruses through expelled saliva microdroplets and aerosols is a significant concern for healthcare workers, further highlighted during the SARS-CoV-2 pandemic. To address this issue, the development of nanomaterials with antimicrobial properties for use as nanolayers in respiratory protection equipment, such as facemasks or respirators, has emerged as a potential solution. In this study, a silver and copper nanolayer called SakCu® was deposited on one side of a spun-bond polypropylene fabric using the magnetron sputtering technique. The antibacterial and antiviral activity of the AgCu nanolayer was evaluated against droplets falling on the material and aerosols passing through it. The effectiveness of the nanolayer was assessed by measuring viral loads of the enveloped virus SARS-CoV-2 and viability assays using respiratory surrogate viruses, including PaMx54, PaMx60, PaMx61 (ssRNA, Leviviridae), and PhiX174 (ssDNA, Microviridae) as representatives of non-enveloped viruses. Colony forming unit (CFU) determination was employed to evaluate the survival of aerobic and anaerobic bacteria. The results demonstrated a nearly exponential reduction in SARS-CoV-2 viral load, achieving complete viral load reduction after 24 hours of contact incubation with the AgCu nanolayer. Viability assays with the surrogate viruses showed a significant reduction in viral replication between 2-4 hours after contact. The simulated viral filtration system demonstrated inhibition of viral replication ranging from 39% to 64%. The viability assays with PhiX174 exhibited a 2-log reduction in viral replication after 24 hours of contact and a 16.31% inhibition in viral filtration assays. Bacterial growth inhibition varied depending on the species, with reductions ranging from 70% to 92% for aerobic bacteria and over 90% for anaerobic strains. In conclusion, the AgCu nanolayer displayed high bactericidal and antiviral activity in contact and aerosol conditions. Therefore, it holds the potential for incorporation into personal protective equipment to effectively reduce and prevent the transmission of aerosol-borne pathogenic bacteria and respiratory viruses.

Indexed as

SilverVirusesAerosolsAntiviral AgentsBacteriaCopperHumansRespiratory Aerosols and DropletsSARS-CoV-2AerosolsAntiviral AgentsCopperSilver

Identifiers

PMID38079398
PMCPMC10712891
OpenAlexW4389547181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.